FDA panel narrowly backs Pfizer RSV vaccine for older adults
WASHINGTON - Federal health advisers on Feb. 28 narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against the respir…
WASHINGTON - Federal health advisers on Feb. 28 narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against the respir…